As Central European nations mark the first anniversary of the outbreak of the COVID-19 pandemic, Slovakia, Czechia, and Poland join Hungary in looking for vaccines outside of joint EU schemes.
Slovak Prime Minister Igor Matovič shocked the nation by covertly inking a deal on importing two million doses of Russian Sputnik V vaccines. The plan was revealed only when a Slovak military cargo airplane embarked to Moscow.
Matovič’s one-man show spiraled into a domestic crisis, sparking an open conflict amongst the governing coalition parties. The move was also panned by the Slovak MFA, with foreign minister Ivan Korčok calling Russian vaccines a “tool of hybrid warfare” and criticizing Matovič‘s red-carpet treatment for the delivery. However, Matovič deflected the criticism, saying that his decision was not based on politics, but rather “saving lives”, citing data that some 10 percent of the Slovak population is willing to be inoculated only if offered the Russian vaccine. Sputnik V has already been given an exemption by the Health Minister for therapeutic use and inoculation is to start in the following weeks.
Unsurprisingly, Matovič‘s comments gained traction in Russian state media and were used to substantiate claims that Sputnik V is facing geopolitical hurdles in Europe. However, the real problem has been the lack of an official request for certification in Europe, with the rolling review by the European Medicines Agency (EMA) starting only on March 4. While EMA discouraged the use of uncertified vaccines, Matovič panned the agency for being too slow.
In Czechia, President Zeman continues to push for the Sputnik V vaccine and officially made a request for the Chinese Sinopharm vaccine as well. On both counts, Zeman has the support of Prime Minister Andrej Babiš, and China and Russia are reportedly willing to deliver. While Zeman argues that EU certification can be circumvented and approval by the Czech drugs regulator will be sufficient, the regulator itself denied such a process is possible. Instead, the Czech Minister of Health would need to grant an exemption—a move he has repeatedly refused to take.
Finally, Poland, which has thus far seemed content to wait for the EU vaccine approval, entered the vaccine game as well. In a call with Chinese President Xi Jinping, Polish President Andrzej Duda communicated Poland's interest in Chinese vaccines. Xi Jinping was reportedly happy to oblige, honoring the pledge he made at the 17+1 summit. However, no specific deal is in sight as talks on the working level are set to continue. Moreover, Polish Health Minister threw cold water on the plans, saying that Poland prefers to use “tested products”.
As China and Russia’s efforts in vaccine diplomacy continue to develop, we will continue to keep a close eye on the situation.
Our esteemed colleague Veronika Blablová has created this handy graphic mapping the use/planned use of Chinese vaccines around the world. We count 55 nations who have received or are to receive Chinese vaccines, with at least seven more actively considering it.